TREATMENT TO PROMOTE WOUND HEALING
    3.
    发明申请

    公开(公告)号:US20180207206A1

    公开(公告)日:2018-07-26

    申请号:US15852443

    申请日:2017-12-22

    IPC分类号: A61K35/62 A61K39/00

    CPC分类号: A61K35/62 A61K39/0003

    摘要: The invention relates to a field of tissue repair and regeneration. More particularly, the invention relates to a composition for promoting cutaneous wound healing. In one embodiment, the composition is composed of one or more metazoan parasites or a mimic thereof sufficient to promote helminth-induced type-2 immune response. Preferably, the composition contains N. brasiliensis excretory/secretory antigen (NES) or an immune triggering portion thereof. The invention also relates to a method of accelerating wound healing in a subject in need of such treatment.

    Treatment to promote wound healing

    公开(公告)号:US09931361B2

    公开(公告)日:2018-04-03

    申请号:US14218189

    申请日:2014-03-18

    IPC分类号: A61K35/62 A61K39/00

    CPC分类号: A61K35/62 A61K39/0003

    摘要: The invention relates to a field of tissue repair and regeneration. More particularly, the invention relates to a composition for promoting cutaneous wound healing. In one embodiment, the composition is composed of one or more metazoan parasites or a mimic thereof sufficient to promote helminth-induced type-2 immune response. Preferably, the composition contains N. brasiliensis excretory/secretory antigen (NES) or an immune triggering portion thereof. The invention also relates to a method of accelerating wound healing in a subject in need of such treatment.

    COMPOSITION FOR PARENTERAL ADMINISTRATION, METHOD FOR PRODUCING AND METHOD USE THEREOF
    9.
    发明申请
    COMPOSITION FOR PARENTERAL ADMINISTRATION, METHOD FOR PRODUCING AND METHOD USE THEREOF 有权
    用于住院管理的组合物,其生产方法及其使用方法

    公开(公告)号:US20150224149A1

    公开(公告)日:2015-08-13

    申请号:US14694290

    申请日:2015-04-23

    摘要: The present invention relates to a field of veterinary and human medicine. In particular, the invention relates to a composition suitable for parenteral administration, based on hydrolyzate obtained from natural bioresources, a composition for use in treating and/or preventing a pathological condition in a mammal in need thereof, and various other uses thereof. More particularly the invention relates to a composition having immunomodulatory properties being based on a hydrolyzate obtained from bioresources, which composition is used for parenteral administration to a mammal in need thereof.

    摘要翻译: 本发明涉及兽医和人类医学领域。 特别地,本发明涉及一种适合肠胃外给药的组合物,其基于天然生物资源获得的水解产物,用于治疗和/或预防有需要的哺乳动物病理状况的组合物及其各种其它用途。 更具体地说,本发明涉及具有免疫调节特性的组合物,其基于从生物资源获得的水解产物,该组合物用于向有需要的哺乳动物肠胃外给药。

    Composition comprising parasite eggs and methods for isolation and storage of parasite eggs
    10.
    发明授权
    Composition comprising parasite eggs and methods for isolation and storage of parasite eggs 有权
    包含寄生虫卵的组合物和用于分离和储存寄生虫卵的方法

    公开(公告)号:US09095595B2

    公开(公告)日:2015-08-04

    申请号:US13331249

    申请日:2011-12-20

    CPC分类号: A61K35/62 C12N5/0601

    摘要: The invention relates to a composition for storage and development of eggs from helminthic parasites, where the composition further comprises a liquid carrier having a pH value of below 7 at a temperature of from 10C to ambient temperature. The liquid carrier can be sulphuric acid, H2SO4 with a pH in the range of from 0 to 2, and antibiotics can be added. The invention further relates to a method for treating, ameliorating, prophylactic or curative, an autoimmune or allergic disease in an individual, animal or man, using eggs being separated from the composition. The present invention also relates to methods for isolation, embryonation and preservation of eggs of helminthic parasite, and to a method for producing a pharmaceutical composition comprising a helminthic parasite preparation. The helminthic parasite eggs may be from the pig whipworm; Trichuris suis ova (TSO).

    摘要翻译: 本发明涉及一种用于储存和发育来自蠕虫寄生虫的卵的组合物,其中组合物还在10℃至室温的温度下包含pH值低于7的液体载体。 液体载体可以是硫酸,pH在0至2范围内的H 2 SO 4,并且可以加入抗生素。 本发明还涉及使用与组合物分离的卵来治疗,改善,预防或治疗个体,动物或人的自身免疫或过敏性疾病的方法。 本发明还涉及用于分离,培养和保存蠕虫寄生虫卵的方法,以及用于生产包含蠕虫寄生虫制剂的药物组合物的方法。 蠕虫寄生虫卵可能来自猪鞭虫; Trichuris suis ova(TSO)。